WILD Program launches within the Victorian STEM sector
22 November 2018 The Women in Leadership Development (WILD) Program announced its launch yesterday, with the first intake of women in the science, technology, engineering and maths (STEM) sector. The WILD Program helps build on the qualifications, skills…
ARC Centre for Personalised Therapeutics Technologies launches in Melbourne
22 November 2018 The ARC Centre for Personalised Therapeutics Technologies launched in Melbourne this week. The centre, headquartered at the Department of Pharmacology and Therapeutics at the University of Melbourne, aims to advance and deploy new technologies that will remove…
Recap: Meet the Minister – a ‘fireside chat’ with Philip Dalidakis, MP
This BioMelbourne Network event recap was written by our Marketing and Communication Assistant, Ms Michelle Steeper. Leaders of Victoria’s health industry joined a Town Hall conversation with the Minister for Innovation and Digital Economy, Hon Philip Dalidakis, MP on…
BioMelbourne Network opposes cuts to the R&D Tax Incentive
5 November 2018 BioMelbourne Network has made a submission to the Senate Inquiry regarding the changes to the R&D Tax Incentive as outlined in the Treasury Laws Amendment. BioMelbourne Network is opposed to the proposed changes to the…
Novartis and BioCurate announce first collaboration to accelerate early stage drug discovery
31 October 2018 Biomedical research company BioCurate Pty Ltd and Novartis today announced that they will collaborate on early stage drug discovery projects that have potential to address an unmet need. This collaboration marks BioCurate’s first with the…
Watermark a first-mover with customised website live chat platform
Being on the leading edge of innovation and intellectual property, Watermark is paving the digital path for IP attorney and legal services firms with the unveiling of a website chat bot. Executive General Manager Mark Bisset says the…
Recap: Meet the Shadow Minister – a ‘fireside chat’ with David Southwick, MP
This BioMelbourne Network event recap was written by our Policy and Research Officer, Dr Kim Pham. Industry leaders, innovators, peak bodies and ASX-listed companies in the health industry recently participated in a Town Hall conversation with Shadow Minister for…
Calls to back the health industry for Victoria’s future
BioMelbourne Network is challenging state election candidates to adopt initiatives that make the health industry a top economic priority for Victoria.
Invention, connection, trust – key ingredients for curating innovation communities
BioMelbourne Network and The Royal Society of Victoria recently hosted the BioBreakfast Curating Innovation Communities featuring the recipients of the 2018 Women in Leadership Awards. One of our volunteers, Aleisha Symon, wrote the following summary of the event. Aleisha is…
Joint statement: The health industry as an economic priority for Victoria
September 2018 Victoria has world-leading competitive advantages in the health industry, which encompasses health and medical research, biotechnology, medical technology, pharmaceuticals, digital health, healthcare delivery, global health and health services. Victoria’s healthcare sector contributes to more than $30…
Immutep enters into clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, and Pfizer
Immutep Limited is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination of Immutep’s lead immunotherapy product candidate eftilagimod alpha…
Burnet’s qDOS Lab a new approach to bringing innovative technologies to market
Fast-tracking innovative technologies through early proof-of-concept and feasibility stages is a key aim of Burnet Institute’s new initiative, the Quick Development of Solutions Lab (qDOS Lab). Nurturing technologies through key early-stage development phases by adopting a market led approach is a primary focus…
